Sustained Release Parenteral Delivery

We have collected information about Sustained Release Parenteral Delivery for you. Follow the links to find out details on Sustained Release Parenteral Delivery.


Sustained-Release Injectable Drug Delivery ...

    http://www.pharmtech.com/sustained-release-injectable-drug-delivery
    Nov 01, 2010 · Reproducible sustained delivery of a drug at a target site is one of the main themes in controlled drug-delivery systems. The most commonly used drug-delivery systems, which can release drugs longer than one week, are parenteral injections and implants.

Sustained Release Drug Delivery Systems: A Patent Overview

    https://www.researchgate.net/publication/270275859_Sustained_Release_Drug_Delivery_Systems_A_Patent_Overview
    Sustained Release Drug Delivery System (SRDDS) is designed to release a drug at a predetermined rate by maintaining a constant drug level for a specific period of time with minimum side effects.

(PDF) Parenteral Drug Delivery: A Review

    https://www.researchgate.net/publication/50938496_Parenteral_Drug_Delivery_A_Review
    In parenteral drug delivery, major progress has been done in the field of formulation technologies so as to provide a targeted and sustained release of drug in predictable manner.

sustained release drug delivery system - SlideShare

    https://www.slideshare.net/prashantmane01/sustained-release-drug-delivery-system
    Nov 25, 2012 · Sustained release, sustained action, prolonged action,controlled release, extended action, time release dosage formed areterms used to identify drug delivery system that are designed toachieve a prolonged therapeutic effect by continuously releasingmedication over an extended period of time after administration ofsingle dose .

FORMULATION FORUM - Drug Development and Delivery

    https://drug-dev.com/formulation-forum-rational-design-development-of-long-acting-injectable-dosage-forms/
    INTRODUCTION. Due to the advantages of parenteral sustained-release drug delivery (also known as long-acting injectables, LAIs), such as reduced toxicity, longer body half-life, reduced dosing frequency, enhanced patient compliance, and overall reduction of medical care cost, different types of sustained-release injectable delivery systems have been introduced to markets, including injectable ...

Recent developments in protein and peptide parenteral ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130463/
    Nonetheless, few research attempts have been made in development of polymeric nanoparticles for parenteral delivery of proteins and peptides. In a recent study, PLGA nanoparticles were developed and characterized as a sustained release system for salmon calcitonin (sCT) . Nanoparticles were prepared by a double emulsion solvent evaporation ...Author: Ashaben Patel, Kishore Cholkar, Ashim K Mitra

Controlling drug delivery for the application of extended ...

    https://repository.library.northeastern.edu/files/neu:772/fulltext.pdf
    Controlling Drug Delivery for the Application of Extended or Sustained-Release Drug Products for Parenteral Administration by Jacklyn O’Neil ABSTRACT OF THESIS Submitted in partial fulfillment of the requirements for the degree of Master of Science in Chemistry in the Graduate School of Arts and Sciences of Northeastern University, May, 2010

Current advances in sustained-release systems for ...

    https://www.ncbi.nlm.nih.gov/pubmed/16296808
    Both the availability of novel carrier materials and the advances in method of fabrication have contributed to these commercial successes. With the formulation challenges associated with biologics, new delivery systems have also been evolved specifically to address the unmet needs in the parenteral sustained release of proteins.Author: Yi Shi, Luk Li

A REVIEW: PARENTERAL CONTROLLED DRUG DELIVERY SYSTEM ...

    https://www.pharmatutor.org/articles/review-parenteral-controlled-drug-delivery-system
    REFERENCE ID: PHARMATUTOR-ART-1477 Introduction The Parenteral administration route is the most effective and common form of delivery for active drug substances with metabolic bio-availabilities drug for which the bio-availability in limited by high first pass metabolism effect of other physicochemical limitation and for drugs with a narrow therapeutic index.

A lipid based depot (DepoFoam® technology) for sustained ...

    https://www.sciencedirect.com/science/article/pii/S0163782702000048
    This article reviews the scientific basis of DepoFoam® technology, a lipid-based drug delivery system. A sustained release depot product (DepoCyt®) utilizing this technology has been clinically developed and recently approved for clinical use by regulatory agencies . DepoFoam formulations of drugs are intended for non-vascular, but parenteral ...Author: Sankaram Mantripragada

Searching for Sustained Release Parenteral Delivery?

You can just click the links above. The data is collected for you.

Related Delivery Info